Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Gastric Cancer

  Free Subscription

Articles published in Oncology

Retrieve available abstracts of 22 articles:
HTML format

Single Articles

    August 2021
  1. NAKAZAWA N, Sohda M, Ide M, Shimoda Y, et al
    High L-Type Amino Acid Transporter 1 Levels Are Associated with Chemotherapeutic Resistance in Gastric Cancer Patients.
    Oncology. 2021 Aug 13:1-8. doi: 10.1159/000517371.
    PubMed     Abstract available

    July 2021
  2. TOKUMARU S, Koizumi T, Sekino Y, Takeuchi N, et al
    Lymphocyte-to-Monocyte Ratio Is a Predictive Biomarker of Response to Treatment with Nivolumab for Gastric Cancer.
    Oncology. 2021 Jul 19:1-9. doi: 10.1159/000517344.
    PubMed     Abstract available

    March 2021
  3. OKUBO K, Arigami T, Matsushita D, Tanaka T, et al
    Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
    Oncology. 2021 Mar 5:1-9. doi: 10.1159/000514572.
    PubMed     Abstract available

    January 2021
  4. JIANG DM, Sim HW, Espin-Garcia O, Chan BA, et al
    Chemoradiotherapy Using Carboplatin plus Paclitaxel versus Cisplatin plus Fluorouracil for Esophageal or Gastroesophageal Junction Cancer.
    Oncology. 2021;99:49-56.
    PubMed     Abstract available

  5. NAMIKAWA T, Maeda M, Yokota K, Iwabu J, et al
    Enteral Vitamin B12 Supplementation Is Effective for Improving Anemia in Patients Who Underwent Total Gastrectomy.
    Oncology. 2021;99:225-233.
    PubMed     Abstract available

  6. ABDELHAKEEM A, Patnana M, Wang X, Rogers JE, et al
    Influence of Baseline Positron Emission Tomography in Metastatic Gastroesophageal Cancer on Survival and Response to Therapy.
    Oncology. 2021;99:659-664.
    PubMed     Abstract available

    October 2020
  7. UBUKATA Y, Ogata K, Sohda M, Yokobori T, et al
    Role of PD-L1 Expression during the Progression of Submucosal Gastric Cancer.
    Oncology. 2020 Oct 28:1-8. doi: 10.1159/000509033.
    PubMed     Abstract available

    September 2020
  8. ARIGAMI T, Matsushita D, Okubo K, Sasaki K, et al
    Clinical Significance of Conversion Surgery for Gastric Cancer with Peritoneal Dissemination: A Retrospective Study.
    Oncology. 2020 Sep 9:1-9. doi: 10.1159/000509530.
    PubMed     Abstract available

  9. NAKAMURA M, Ojima T, Katsuda M, Hayata K, et al
    Phase 1 Study of Combined Chemotherapy of Nab-Paclitaxel, S-1, and Oxaliplatin for Gastric Cancer with Peritoneal Metastasis (NSOX Study).
    Oncology. 2020 Sep 2:1-5. doi: 10.1159/000509396.
    PubMed     Abstract available

    June 2020
  10. ZHOU J, Zhao Z, Zhang Y, Bao C, et al
    Pathogenic Germline Mutations in Chinese Patients with Gastric Cancer Identified by Next-Generation Sequencing.
    Oncology. 2020 Jun 10:1-6. doi: 10.1159/000505664.
    PubMed     Abstract available

    May 2020
  11. AHOPELTO K, Laitinen A, Hagstrom J, Bockelman C, et al
    Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
    Oncology. 2020 May 20:1-10. doi: 10.1159/000507350.
    PubMed     Abstract available

  12. ARIGAMI T, Matsushita D, Okubo K, Yanagita S, et al
    Response Rate and Prognostic Impact of Salvage Chemotherapy after Nivolumab in Patients with Advanced Gastric Cancer.
    Oncology. 2020 May 19:1-7. doi: 10.1159/000507219.
    PubMed     Abstract available

  13. ITO S, Masuda T, Noda M, Hu Q, et al
    Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
    Oncology. 2020 May 7:1-11. doi: 10.1159/000506075.
    PubMed     Abstract available

    April 2020
  14. DI PINTO F, Armentano R, Arborea G, Schena N, et al
    Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification?
    Oncology. 2020 Apr 21:1-9. doi: 10.1159/000506077.
    PubMed     Abstract available

    March 2020
  15. NAMIKAWA T, Yokota K, Yamaguchi S, Iwabu J, et al
    Evaluation of Systemic Inflammatory Response and Nutritional Biomarkers as Predictive Factors in Patients with Recurrent Gastric Cancer.
    Oncology. 2020 Mar 17:1-8. doi: 10.1159/000505973.
    PubMed     Abstract available

    February 2020
  16. ARIGAMI T, Matsushita D, Okubo K, Kawasaki Y, et al
    Indication and Prognostic Significance of Conversion Surgery in Patients with Liver Metastasis from Gastric Cancer.
    Oncology. 2020 Feb 14:1-7. doi: 10.1159/000505555.
    PubMed     Abstract available

    January 2020
  17. WAKAHARA T, Kanemitsu K, Asari S, Tsuchida S, et al
    The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective Gastrectomy.
    Oncology. 2020;98:111-116.
    PubMed     Abstract available

  18. ROGERS JE, Xiao L, Trail A, Blum Murphy M, et al
    Nivolumab in Combination with Irinotecan and 5-Fluorouracil (FOLFIRI) for Refractory Advanced Gastroesophageal Cancer.
    Oncology. 2020;98:289-294.
    PubMed     Abstract available

  19. MIZRAK KAYA D, Nogueras Gonzalez GM, Harada K, Blum Murphy MA, et al
    Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma.
    Oncology. 2020;98:542-548.
    PubMed     Abstract available

  20. WUNDSAM HV, Doleschal B, Prommer R, Venhoda C, et al
    Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis.
    Oncology. 2020;98:706-713.
    PubMed     Abstract available

  21. ABDELHAKEEM A, Wang X, Rogers JE, Trail A, et al
    Outcomes of Advanced Gastroesophageal Cancer Patients with Equivocal HER2 Expression with or without ERBB2 Gene Amplification.
    Oncology. 2020;98:884-888.
    PubMed     Abstract available

    September 2019
  22. JUNG DH, Bae YJ, Kim JH, Shin YK, et al
    HER2 Regulates Cancer Stem Cell Activities via the Wnt Signaling Pathway in Gastric Cancer Cells.
    Oncology. 2019 Sep 24:1-8. doi: 10.1159/000502845.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.